comparemela.com

Page 8 - Jay Mei News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to.

Hong kongSouth koreaJun maJianxiang wangJay meiAsia pacificPeter qianXiaojun huangDepei wuCompany annualAntengene corporationNational cancer care networkEuropean society of medical oncologyShanghai pharmaceutical co ltdChina national medical products administrationHealth commerce co ltd

Antengene to Participate in Three Upcoming Investor Conferences in May/June

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Hong kongSouth koreaJay meiAsia pacificPeter qianCompany annualAntengene corporationHong kong stock exchangePrnewswire antengene corporation limitedHealthcare industry forumAntengene corporation limitedCicc healthcare industry forumVirtual company presentationIndustry forumChina biotech dayPan asia regional investor conference

Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to.

United statesHong kongSouth koreaJay meiAsia pacificPeter qianSelective inhibitor of nuclear exportKaryopharm therapeutics incCompany annualAntengene corporationDrug administrationAmerican society of hematologyChina national medical products administrationHong kong stock exchangePrnewswire antengene corporation limitedAntengene corporation limited

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to.

United statesHong kongSouth koreaJay meiAsia pacificPeter qianBristol myers squibbCompany annualAntengene corporationAmerican society of clinical oncologyAmerican society of hematology annual meetingEuropean hematology associationManufacturing centerCalithera biosciences incLegochem biosciences incNational comprehensive cancer network

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to.

United statesHong kongSouth koreaJay meiAsia pacificPeter qianBristol myers squibbCompany annualAntengene corporationAmerican society of clinical oncologyAmerican society of hematology annual meetingEuropean hematology associationManufacturing centerCalithera biosciences incLegochem biosciences incNational comprehensive cancer network

vimarsana © 2020. All Rights Reserved.